Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients

被引:54
|
作者
Wen, Shi-Rong [2 ]
Liu, Guo-Jun [2 ]
Feng, Ren-Nan [3 ]
Gong, Feng-Chao [2 ]
Zhong, Hua [2 ]
Duan, Shu-Rong [2 ]
Bi, Sheng [1 ,2 ]
机构
[1] Harbin Med Coll, Cent Lab, Affiliated Hosp 1, Harbin 150001, Peoples R China
[2] Harbin Med Coll, Dept Neurol, Affiliated Hosp 1, Harbin 150001, Peoples R China
[3] Harbin Med Coll, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin 150001, Peoples R China
关键词
Osteopontin; IL-23; Multiple sclerosis; DENDRITIC CELLS; MESSENGER-RNA; PATHOGENESIS; EXPRESSION; CORRELATE; DISEASE;
D O I
10.1016/j.jneuroim.2011.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteopontin (OPN) and interleukin-23 (IL-23) are pro-inflammatory cytokines proposed to play central roles to the development of multiple sclerosis (MS). The aim of this study was to evaluate levels of OPN, IL-23 and other inflammatory cytokines and investigate their relationships in serum and cerebrospinal fluid (CSF) in patients with MS. Fifty one MS patients and 48 patients with non-inflammatory neurological diseases (NIND) were recruited from clinic. The levels of OPN, IL-23, IL-17, IL-6, and tumor necrosis factor-alpha (TNF-alpha) in serum and CSF were determined in each participant. Compared with NIND group, MS patients had significantly elevated levels of OPN, IL-23, IL-17 and TNF-alpha in CSF, and elevated levels of IL-23, IL-17 and TNF-alpha in serum (All P<0.001). In MS patients, OPN and IL-23 were positively correlated with IL-17 (r = 0.302, P=0.019; r = 0.417, P=0.001, respectively); and IL-23 was positively correlated with EDSS (r = 0.329, P=0.019). Both OPN and IL-23 may play pivotal role in development of MS and might be specific markers and therapeutic targets for MS. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:94 / 96
页数:3
相关论文
共 50 条
  • [21] Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis
    Fissolo, Nicolas
    Cervera-Carles, Laura
    Villar Guimerans, Luisa Maria
    Lleo, Alberto
    Clarimon, Jordi
    Drulovic, Jelena
    Dujmovic, Irena
    Voortman, Margarete
    Khalil, Michael
    Gil, Elia
    Navarro, Laura
    Carlos Alvarez-Cermeno, Jose
    Montalban, Xavier
    Comabella, Manuel
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (11) : 1535 - 1538
  • [22] Elevated lysophosphatidic acid levels in the serum and cerebrospinal fluid in patients with multiple sclerosis: therapeutic response and clinical implication
    Jiang, Dongxiao
    Ju, Weiping
    Wu, Xijun
    Zhan, Xia
    NEUROLOGICAL RESEARCH, 2018, 40 (05) : 335 - 339
  • [23] Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis
    Wu, Aimin
    Zhong, Xiaonan
    Wang, Honghao
    Xu, Wen
    Cheng, Chen
    Dai, Yongqiang
    Bao, Jian
    Qiu, Wei
    Lu, Zhengqi
    Hu, Xueqiang
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (06) : 813 - 820
  • [24] Increased serum levels of some inflammatory markers in patients with multiple sclerosis
    Uysal, S.
    Yilmaz, F. Meric
    Bogdaycioglu, N.
    Ozturk, S. Mungan
    Ak, F.
    MINERVA MEDICA, 2014, 105 (03) : 229 - 235
  • [25] Serum and cerebrospinal fluid soluble Fas levels in clinical subgroups of multiple sclerosis
    Boylan, MT
    Crockard, AD
    McDonnell, GV
    McMillan, SA
    Hawkins, SA
    IMMUNOLOGY LETTERS, 2001, 78 (03) : 183 - 187
  • [26] The effect of corticosteroids on serum and cerebrospinal fluid nitric oxide levels in multiple sclerosis
    Keles, MS
    Taysi, S
    Aksoy, H
    Sen, N
    Polat, F
    Akcay, F
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (09) : 827 - 829
  • [27] Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development
    Kivisaekk, Pia
    Healy, Brian C.
    Francois, Katiana
    Gandhi, Roopali
    Gholipour, Taha
    Egorova, Svetlana
    Sevdalinova, Velina
    Quintana, Francisco
    Chitnis, Tanuja
    Weiner, Howard L.
    Khoury, Samia J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (04) : 438 - 444
  • [28] Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis
    Giovannoni, G
    MULTIPLE SCLEROSIS, 1998, 4 (01): : 27 - 30
  • [29] Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica
    Qi, Yuan
    Jia, Kun
    Zhang, Da-Qi
    Li, Ting
    Li, Li-Min
    Zhang, Lin-Jie
    Wang, Jing
    Gao, Chun-Li
    Sun, Li-Sha
    Shi, Fu-Dong
    Yang, Li
    CLINICA CHIMICA ACTA, 2016, 456 : 176 - 179
  • [30] Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica
    Kariya, Yoshinobu
    Kariya, Yukiko
    Saito, Toshie
    Nishiyama, Shuhei
    Honda, Takashi
    Tanaka, Keiko
    Yoshida, Mari
    Fujihara, Kazuo
    Hashimoto, Yasuhiro
    BBA CLINICAL, 2015, 3 : 126 - 134